DOMESTIC MYOCARDIAL CYTOPROTECTOR EFFECTIVENESS AND ITS PHARMACODYNAMICS IN ACUTE MYOCARDIAL ISCHEMIA: CLINICAL RESULTS AND EXPERIMENTAL MODELS
Anti-ischemic effects of high-dose cardiac cytoprotector Mexicor (0,014 g/kg/d, 0,019 g/kg/d) were examined in rabbits with experimental myocardial infarction. In addition, anti-ischemic activity of Mexicor (0,4 g/d) was assessed in patients with acute coronary syndrome (ACS). It has been demonstrat...
Saved in:
| Main Authors: | V. P. Mikhin, M. V. Pokrovskyi, V. V. Gureev, O. A. Chernova, Yu. V. Alimenko, E. N. Bogoslovskaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2011-04-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1101 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
State stiffness parameters of the vascular wall in hypertensive patients complex therapy cytoprotector and sartans
by: V. P. Mikhin, et al.
Published: (2015-10-01) -
Myocardial ischemia – reperfusion injury
by: S. V. Salo, et al.
Published: (2023-10-01) -
Refractory post-infarction myocardial ischemia: treatment potential
by: V. V. Ryabov, et al.
Published: (2011-08-01) -
Prevalence and prognostic significance of silent myocardial ischemia in patients after myocardial infarction
by: Deljanin-Ilić Marina Ž., et al.
Published: (2007-01-01) -
CYTOPROTECTOR MILDRONATE IN CORRECTING MYOCARDIAL DYSFUNCTION AMONG STABLE ANGINA PATIENTS AFTER CORONARY REVASCULARISATION
by: I. G. Gordeev, et al.
Published: (2009-04-01)